Literature DB >> 14750105

Treatment of proliferative lupus nephritis.

James E Balow, Howard A Austin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14750105     DOI： 10.1053/j.ajkd.2003.12.008

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  2 in total

1.  An Analysis of the Correlation Between Clinical Indexes and Pathological Classifications in 202 Patients with Lupus Nephritis.

Authors:  Bang-Pin Pan; Zhi-Jian Feng; Xiao-Lan Li; Li-Ping He; Dong Jiang; Rui-Xian Zhang; Wen-Ting Cao; Mei Cai; Yun-Feng Bi; Wen-Fang Wang; Chun-Yan Luan
Journal:  J Inflamm Res       Date:  2021-12-16

2.  Intravenous cyclophosphamide--resistant systemic lupus erythematosus in Arizona.

Authors:  Mehul P Dixit; Erika Bracamonte; Naznin Dixit
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.